Crossmark

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41571-018-0074-3

Published Online: 2018-07-26

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cabel, Luc

Proudhon, Charlotte

Romano, Emanuela

Girard, Nicolas

Lantz, Olivier https://orcid.org/0000-0003-3161-7719
Stern, Marc-Henri

Pierga, Jean-Yves

Bidard, François-Clément https://orcid.org/0000-0001-5932-8949
License Information

Text and Data Mining valid from 2018-07-26
More Information

Article History

First Online: 26 July 2018

Competing interests

: C.P., M.-H.S., and F.-C.B. have ongoing patent applications relating to circulating tumour DNA analysis. The other authors declare no competing interests.